By physician referral or invitation only

Efficacy and Safety of Icotrokinra in Participants with Moderately to Severely Active Crohn's Disease

Phase 2b Induction: To evaluate the efficacy of icotrokinra versus placebo in inducing clinical response Phase 3 Induction: To evaluate the efficacy of icotrokinra versus placebo in induction Phase 3 Maintenance: To evaluate the efficacy of icotrokinra versus placebo in maintenance

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Animesh Jain
Medicine-Gastroenterology

Study Type

Clinical or Medical
Interventional

Study Topics

Stomach, Digestion and Gut Health

IRB Number

25-2144

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.